Valneva and Pfizer Enter into an Equity Subscription Agreement and Update Terms of Collaboration Agreement for Lyme Disease Vaccine Candidate VLA15
SAINT-HERBLAIN, France & NEW YORK--(BUSINESS WIRE)--Jun 20, 2022--
SAINT-HERBLAIN, France & NEW YORK--(BUSINESS WIRE)--Jun 20, 2022--